Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

Despite an unusual lack of major announcements, energy is high. And a few key themes dominate discussions.

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA.

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

International pharmaceutical leaders and investors gathered in San Francisco on Sunday to explore partnership opportunities ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...